Keywords: Psychiatric Disorders, Psychiatric Disorders, Machine learning
Motivation: The research aims to improve diagnostic accuracy and treatment strategies for First-Episode Psychosis by identifying critical brain iron biomarkers.
Goal(s): The present study aims to pinpoint potential predictive biomarkers derived from QSM and R2* for individuals experiencing first-episode-psychosis (FEP), along with their response to antipsychotic treatment.
Approach: The study used MRI to assess brain iron levels in psychosis patients, employing machine learning for classification and treatment response prediction.
Results: The study achieved 76.48% accuracy in classifying healthy individuals from First-Episode Psychosis patients and 76.43% accuracy in predicting treatment responses, identifying key biomarkers linked to dopamine pathways.
Impact: This study identifies key brain iron concentration biomarkers using QSM and R2* in FEP, achieving 76% classification accuracy. It highlights the potential for improved early detection and treatment response prediction, paving the way for enhanced clinical outcomes in schizophrenia management.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords